Jolynn Tumolo

News

Pharmacist-Physician Collaboration Improves Pediatric Hypertension Outcomes

01/05/2024

Jolynn Tumolo

Pharmacist-physician collaborative drug therapy management improved outcomes compared with traditional care in pediatric patients with hypertension, according to a single-clinic study published in The Journal of Pediatric Pharmacology and...

Pharmacist-physician...

01/05/2024

Pharmacy Learning Network

News

PCA Rx Partners With Cost Plus Drugs to Bring Transparency to Drug Pricing

01/05/2024

Jolynn Tumolo

Pharmacy benefit manager PCA Rx recently announced a collaboration with Mark Cuban Cost Plus Drug Company to offer employers and members clarity and openness in drug pricing in an industry known for hidden costs.

Pharmacy benefit manager PCA Rx...

01/05/2024

Pharmacy Learning Network

News

Teen’s Vocal Cord Paralysis Deemed Complication of COVID-19

01/04/2024

Jolynn Tumolo

Vocal cord pathology should be considered in children and teens who experience voice, swallowing, or breathing difficulties after SARS-CoV-2 infection, suggests a case report published online ahead of print in the journal Pediatrics.

Vocal cord pathology should be...

01/04/2024

Integrated Healthcare Executive

News

Antibiotic Pulled

01/03/2024

Jolynn Tumolo

Cardinal Healthcare pulled three units of amoxicillin for oral suspension because it was exposed to temperatures outside its labeled storage conditions. The recall was included in the January 3, 2024, US Food and Drug Administration (FDA)...

Cardinal Healthcare pulled three...

01/03/2024

Pharmacy Learning Network

News

Uric Acid Reducer Recalled

01/03/2024

Jolynn Tumolo

Allopurinol tablets were recalled by Cardinal Healthcare due to exposure to temperatures outside labeled storage conditions, according to the January 3, 2024, US Food and Drug Administration (FDA) Enforcement Report.

Allopurinol tablets were...

01/03/2024

Pharmacy Learning Network

News

COPD Drug Recalled

01/03/2024

Jolynn Tumolo

Cardinal Healthcare voluntarily initiated the recall January 26, 2022. On December 26, 2023, the FDA designated the recall Class II. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if...

Cardinal Healthcare voluntarily...

01/03/2024

Pharmacy Learning Network

News

Vitamin B6 Plus Lithium Helps Ease Mania Symptoms in Patients With Bipolar Disorder

01/03/2024

Jolynn Tumolo

Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.

Daily vitamin B6 as adjunctive...

01/03/2024

Psych Congress Network

News

Perseverative Behaviors Warrant Attention in Patients With Huntington Disease

12/28/2023

Jolynn Tumolo

Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...

Separate reporting of...

12/28/2023

Neurology

News

Deep Transcranial Magnetic Stimulation for OCD Likely to Ease Depressive Symptoms

12/28/2023

Jolynn Tumolo

Patients who received deep transcranial magnetic stimulation (dTMS) for OCD showed a significant improvement in both OCD and depressive symptoms, according to a study published in the Journal of Affective Disorders.

Patients who received deep...

12/28/2023

Psych Congress Network

News

For Treatment-Resistant Depression, Ketamine and ECT Offer Similar Effectiveness

12/24/2023

Jolynn Tumolo

Seemingly contradictory findings from recent studies comparing intravenous (IV) ketamine with electroconvulsive therapy (ECT) in outpatients with treatment-resistant depression may have practicing clinicians feeling unsure about which...

Seemingly contradictory findings...

12/24/2023

Psych Congress Network